A Phase 2 Multicenter Study Evaluating the Efficacy of KTE-C19 in Subjects with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL)

Type of Cancer
Lymphoma

Site
Hackensack

Sponsor
Kite Pharma

Protocol Number
Kite Pharma KTE-C19-102

To Learn More Call
201-510-0910